Treatment-Resistant Depression: Treatments & Medications

Have you tried multiple antidepressants, only to realise none have been effective? It’s common to experience this due to a science-backed reason. A state known as 'treatment-resistant depression'—a major depressive disorder that does not improve health even after one or more  treatments. This affects a meaningful share of people grappling with depression.

If this sounds familiar, you are not alone, and you are not out of options. This guide walks through what treatment-resistant depression actually means, why it happens, and the full range of treatments available: from antidepressants and psychotherapy to ketamine, esketamine, TMS, and **ECT. **

What Is Treatment-Resistant Depression?

Treatment-resistant depression is a form of major depressive disorder that does not improve adequately even after one or more appropriate treatments, such as antidepressant medication or psychotherapy. It is not a separate diagnosis and is, moreover, a description of how depression has responded to care so far.

One experiences treatment-resistant depression even when they’ve tried different antidepressants at an appropriate dose for an appropriate length of time.

‍

Treatment-resistant depression is common, and affects roughly a third of people with major depressive disorder, according to the National Institute of Mental Health.

‍

Clinicians typically consider depression treatment-resistant when someone has completed two or more adequate antidepressant trials, with the right dose for at least four to eight weeks, without a meaningful drop in symptoms. This is different from medication-resistant depression though the two terms often describe the same experience. Some clinicians use "medication-resistant" more narrowly, for cases where medication specifically has failed, while "treatment resistance” can include psychotherapy as well.

Why doesn't every antidepressant work for each person? Depression has multiple biological pathways, and no single medication targets all of them. This is exactly why working with a mental health professional matters: a clinician can track your treatment response over time and adjust course, rather than leaving you to guess.

What Causes Treatment-Resistant Depression?

Depression can persist despite treatment for several overlapping reasons and rarely just one. Understanding these factors helps explain why "trying harder" on the same medication is not always the answer.

Common contributors include:

• Incorrect diagnosis or an underlying condition. Bipolar disorder, thyroid dysfunction, or another mood or medical condition can look like standard depression at first.
• Inadequate dose or treatment duration. Many antidepressant trials fail simply because the dose was too low or was stopped too soon, before four to eight weeks.
• Medication adherence. Missed doses, side effects that lead to stopping early, or inconsistent use can all blunt treatment response.
• Co-occurring anxiety or other mental health conditions, which can mask or complicate depression symptoms.
• Substance use, including alcohol, which can interfere with how antidepressants work.
• Chronic stress and environmental factors, such as ongoing financial strain, grief, or relationship difficulty.
• Underlying medical conditions, like thyroid disorders, chronic pain, or vitamin deficiencies, that can affect mood.
• Genetic and biological factors that influence how your body metabolizes and responds to specific medications.

Because so many of these factors overlap, reassessing the diagnosis is often the first and most important step, according to guidance from Harvard Health. A clinician who revisits your full history, not just your current prescription, is more likely to understand why you’re resistant to treatment.

How Is Treatment-Resistant Depression Diagnosed?

There is no single blood test for treatment-resistant depression. Instead, clinicians diagnose it through a structured review of your depression symptoms, treatment history, and response to prior care.

That review typically includes:

1. A detailed look at current depression symptoms and how long they have lasted.
2. A full treatment and medication history, including every antidepressant tried.
3. The number of previous antidepressant trials, since most definitions require at least two.
4. Confirmation that dose and duration were adequate for each trial, not just that a prescription was filled.
5. A review of response and side effects from each previous medication.
6. An assessment of psychotherapy history, including type and consistency.
7. Screening for bipolar disorder and other conditions that can mimic or complicate depression.

Clinicians often use standardized rating scales, such as the PHQ-9, to measure treatment response over time rather than relying on a single conversation. This gives a clearer, more objective picture of whether a treatment is actually working.

This step matters because "treatment-resistant" is sometimes actually "pseudo-resistant," meaning the prior treatment was never given a fair chance. A careful diagnostic review, done by a qualified mental health professional, is what separates the two.

Best Antidepressants for Treatment-Resistant Depression

There is no single best antidepressant for treatment-resistant depression that works for everyone. Antidepressant selection is highly individualized, based on your symptoms, medical history, prior response, and side effect tolerance.

That said, several classes are commonly considered:

Switching from one antidepressant to another is common and does not mean treatment has failed. A prescriber weighs your prior response, side effects, other medications, and any co-occurring conditions before recommending a change, according to prescribing guidance summarized by the National Library of Medicine.

Klearmind's guide to Zoloft and Lexapro alternatives and both walk through this decision process in more depth. You can read more here.

A landmark real-world study, the NIMH-funded STAR*D trial, followed thousands of patients through sequential antidepressant trials. It found that with each additional medication tried, the odds of remission dropped, which is part of why clinicians now move to combination or augmentation strategies sooner rather than later.

Treatment-Resistant Depression Medication Options

When an initial antidepressant does not provide enough relief, clinicians generally move through a series of medication strategies rather than starting over from scratch. This is what most people mean by treatment-resistant depression medication planning.

Common approaches include:

• Switching antidepressants to a different class or drug within the same class.
• Combining antidepressants by using two medications with complementary mechanisms.
• Augmentation strategies include adding a second type of medication to boost the effect of the first, known as medication augmentation.
• Atypical antipsychotic medications as augmentation, such as aripiprazole or quetiapine, which have research support for treatment-resistant cases, according to reviews published in JAMA Psychiatry.
• Other augmentation options, including lithium or thyroid hormone (T3), used off-label in some cases.

How are these combinations chosen? Your prescriber weighs your symptom pattern, side effect history, other health conditions, and how you responded to earlier trials. Close monitoring for effectiveness and side effects continues throughout, since combining medications can also combine risks.

One point matters more than any single drug name: medications for treatment-resistant depression should only be changed under medical supervision. Stopping or combining antidepressants on your own can be unsafe.

Other Treatments for Treatment-Resistant Depression

Medication is not the only path forward. Several evidence-based treatments exist beyond conventional antidepressants, and many people combine two or more approaches for the best result.

Psychotherapy, particularly cognitive behavioral therapy (CBT), remains a core part of treatment for many people, whether used alone or alongside medication. It helps address the thought patterns and behaviors that can keep depression in place.

For more resistant cases, clinicians may consider:

• Electroconvulsive therapy (ECT): One of the most effective treatments for severe, treatment-resistant depression, according to research summarized by the American Journal of Psychiatry. It does carry a real side effect profile, including short-term memory effects, and is typically reserved for more severe cases.
• Transcranial magnetic stimulation (TMS): A non-invasive option that uses magnetic pulses to stimulate areas of the brain involved in mood regulation. This is generally delivered daily over several weeks.
• Ketamine therapy: An infusion-based treatment that acts on different brain pathways than standard antidepressants and may offer relief within hours to days for some people, per research reviewed by the NIH.
• Esketamine nasal spray: An FDA-approved treatment for treatment-resistant depression, administered under medical supervision in a clinical setting due to monitoring requirements.

Ketamine is FDA-approved as an anesthetic, and its use for depression, whether IV or otherwise, is generally an off-label application, while esketamine (brand name Spravato) carries its own specific FDA approval for treatment-resistant depression.

If earlier medication trials have not helped and your symptoms remain severe or persistent, options like ketamine-assisted therapy are worth discussing with a clinician who can evaluate whether it fits your specific history. Klearmind's own reported outcomes, for context, show relief often beginning one to two hours after an initial infusion for many patients, though this is the clinic's own observed result, not a universal guarantee.

Klearmind's guide to ketamine treatment for depression and its comparison of ketamine versus ECT in depression both go deeper into how these two approaches differ, including risk and reward. The clinic's piece debunking the top misconceptions about ketamine therapy is also worth a look if concerns about safety are part of what's holding you back.

For a clinical overview of how psychiatrists actually reason through these treatment decisions, Johns Hopkins Psychiatry's public Grand Rounds talk on treatment-resistant depression, presented by Dr. Karen Swartz, walks through the same decision tree in more depth.

Each option carries its own benefits, limits, and possible side effects, which is exactly why an individualized treatment plan, built with a qualified clinician, matters more than any single "best" option.

How Long Does Treatment-Resistant Depression Treatment Take?

Finding an effective answer for treatment-resistant depression usually takes time, and that is normal, not a sign that something is wrong. Most antidepressants take four to eight weeks at an adequate dose to show their full effect.

That means each medication trial requires patience:

• Standard antidepressants: typically 4-8 weeks to assess a full trial.
• Medication switches or augmentation: another 4-8 week window to evaluate.
• TMS: usually delivered over 4-6 weeks of daily sessions.
• Ketamine or esketamine: Some people notice change within hours to days, though a full course is usually needed to assess lasting benefit.

Monitoring symptom improvement along the way, often with a standardized scale, helps your clinician tell the difference between a partial response and true remission. Partial improvement is still meaningful progress, and it often shapes the next step, whether that means adjusting the dose or adding a second treatment.

Because of how antidepressants work in the body, treatment should never be stopped abruptly. Doing so can cause withdrawal-like symptoms and a rebound in depression symptoms. If a strategy is not working after an adequate trial, that is the moment to revisit the plan with your prescriber, not to stop treatment altogether.

What Can You Do If Depression Treatment Is Not Working?

If your current treatment is not helping enough, the most important step is to talk to your prescribing clinician rather than deciding on your own that nothing works. There is almost always a next step to try.

From there, it helps to:

• Review medication adherence and dosage together, since missed doses or a too-low dose are common, fixable blockers.
• Discuss side effects openly, since these often explain why a treatment was stopped too early.
• Ask about reassessing the diagnosis, particularly if mood swings, anxiety, or a medical condition could be part of the picture.
• Consider adding psychotherapy if you have only tried medication so far.
• Ask about switching or augmentation strategies, including atypical antipsychotics or lithium.
• Discuss TMS, ECT, ketamine, or esketamine when appropriate for your symptom severity.
• Track your symptoms and treatment response between visits, since a clear record helps your clinician see patterns you might miss day to day.

Keeping a simple weekly log of mood, sleep, and side effects, even a few lines, gives your clinician far more to work with than an "I still feel bad" response. Patterns over weeks matter more than any single hard day.

Above all, avoid changing medication or dosage without medical guidance, even when frustration makes that tempting. Depression that resists one plan often responds to the next one.

Medical disclaimer: This article is for informational purposes only and is not medical advice. Talk to a qualified healthcare provider before starting, stopping, or changing any treatment or supplement.

Final Verdict: Finding the Right Treatment for Treatment-Resistant Depression

Treatment-resistant depression can be challenging, but not responding to an initial antidepressant does not mean that effective treatment is impossible. Medication changes, psychotherapy, augmentation strategies, and other evidence-based treatments may provide additional options. There is no single best antidepressant for everyone, which is exactly why individualized care, built around your history and response, tends to outperform a one-size-fits-all approach.

If you have tried more than one antidepressant without adequate relief, that is the moment to seek out a mental health professional who specializes in treatment-resistant cases, rather than assuming this is simply how things will stay.

Frequently Asked Questions

What is treatment-resistant depression?

Treatment-resistant depression is major depressive disorder that has not improved adequately after one or more appropriate treatments, typically two or more antidepressant trials at an adequate dose and duration. It is a description of treatment history, not a separate standalone diagnosis, and a mental health professional can help confirm whether it applies to you.

What is the best antidepressant for treatment-resistant depression?

There is no single best antidepressant for treatment-resistant depression that works for everyone. Options span SSRIs, SNRIs, atypical antidepressants, TCAs, and MAOIs, and selection depends on your symptoms, prior response, and side effect tolerance, decided together with your prescriber.

What medication is used for treatment-resistant depression?

Treatment-resistant depression medication approaches include switching antidepressants, combining two antidepressants, and augmentation with medications like atypical antipsychotics, lithium, or thyroid hormone. Esketamine nasal spray is also FDA-approved specifically for this indication.

What is medication-resistant depression?

Medication-resistant depression generally refers to depression that has not responded to antidepressant medication specifically, sometimes used interchangeably with treatment-resistant depression, which can also include a lack of response to psychotherapy. Either way, it signals that the current approach needs to change, not that no approach will work.

What do you do when antidepressants do not work?

Talk to your prescribing clinician rather than stopping on your own. From there, reviewing dose and adherence, discussing side effects, reassessing the diagnosis, and considering augmentation, switching, or additional treatments like TMS or ketamine are all reasonable next steps.

How many antidepressants do you have to try before depression is considered treatment-resistant?

Most clinical definitions require at least two adequate antidepressant trials, from different classes or mechanisms, each given at a proper dose for four to eight weeks, without adequate improvement. Some definitions use a higher threshold, so a clinician's overall assessment matters more than any single number.

Can treatment-resistant depression be cured?

Many people with treatment-resistant depression do achieve significant symptom relief or remission with the right combination of treatments, though outcomes vary and depression can be a recurring condition for some. "Cure" is not a term clinicians use lightly, but sustained, meaningful improvement is a realistic goal for many.

Is ketamine effective for treatment-resistant depression?

Research reviewed by the NIH suggests ketamine may help relieve treatment-resistant depression symptoms for many people, sometimes within hours to days, though its use for depression is generally off-label since it is FDA-approved as an anesthetic. It is typically administered under medical supervision, with esketamine nasal spray offering an FDA-approved alternative for this specific use.

Is TMS effective for treatment-resistant depression?

Transcranial magnetic stimulation has research support as an effective, non-invasive option for treatment-resistant depression, typically delivered over daily sessions across four to six weeks. It is generally well tolerated, though responses vary, and it is usually considered after standard medication trials have not provided enough relief.

When is ECT used for treatment-resistant depression?

Electroconvulsive therapy is typically reserved for more severe or urgent cases of treatment-resistant depression, including situations involving significant safety concerns, when other treatments have not provided adequate relief. It has among the strongest evidence bases of any depression treatment, according to research summarized by the American Journal of Psychiatry, though it does carry a real side effect profile that a clinician will review with you in detail.

‍